Biocompatibles

Biocompatibles

File:Biocompatibles logo.png

Biocompatibles logo

Biocompatibles is a company that specializes in the development and commercialization of innovative medical devices and drug-device combination products. The company is known for its work in the field of interventional medicine, particularly in the areas of oncology, cardiology, and ophthalmology.

History

Biocompatibles was founded in 1984 and has since grown to become a leader in the development of biocompatible materials and technologies. The company initially focused on the development of phosphorylcholine (PC) technology, which mimics the outer surface of a cell membrane, making it highly biocompatible. This technology has been applied in various medical devices to improve their compatibility with human tissues.

Technologies

Biocompatibles' core technology is based on phosphorylcholine, which is used to coat medical devices to reduce thrombosis and inflammation. This technology has been applied in a range of products, including stents, catheters, and contact lenses.

Drug-Eluting Beads

One of the key innovations from Biocompatibles is the development of drug-eluting beads, which are used in the treatment of cancer. These beads can be loaded with chemotherapy drugs and delivered directly to a tumor site, providing targeted therapy with reduced systemic side effects. This technology is particularly used in the treatment of liver cancer and other solid tumors.

Ophthalmic Devices

In the field of ophthalmology, Biocompatibles has developed products that utilize its biocompatible coatings to improve the performance and safety of intraocular lenses and other devices used in cataract surgery.

Acquisition

In 2010, Biocompatibles was acquired by BTG plc, a global healthcare company. This acquisition allowed Biocompatibles to expand its reach and continue its research and development efforts under the umbrella of a larger organization.

Current Focus

Today, Biocompatibles continues to innovate in the field of interventional medicine, focusing on the development of new drug-device combination products that improve patient outcomes and reduce healthcare costs. The company collaborates with healthcare professionals and researchers to bring new technologies to market.

Related Pages

• Interventional radiology
• Drug delivery
• Medical device
• Biomaterials